Target intelligence / Profile preview

Histone H2A type 1-J (H2AC14)

Target
H2AC14
Molecular classification
Histone, Core histone protein, DNA-binding protein, Chromatin-associated protein
01

Overview

Histone H2A type 1-J (H2AC14) is a member of the core histone H2A family, encoded by the intronless gene HIST1H2AJ on chromosome 6p22-p21.3[4][6]. Like other H2A histones, it forms part of the histone octamer around which DNA is wrapped in nucleosomes—structures fundamental to chromatin organization in eukaryotic cells[4][5][6]. Two molecules each of H2A, H2B, H3, and H4 form the nucleosome core, enabling compaction and regulation of DNA accessibility[4][5]. H2A family members are critical for genome stability, chromatin higher-order packaging, and modulation of gene transcription by modifying nucleosome dynamics and thereby impacting DNA repair, replication, and transcriptional processes[2][4]. H2A type 1-J is a canonical, replication-dependent histone lacking a polyA tail, instead terminating with a palindromic sequence[4][6]. While core histones and their variants play fundamental roles in cellular proliferation and gene regulation, to date, H2A type 1-J itself is not considered a unique therapeutic target, nor are there clinical drugs or established diagnostics directly involving this specific protein. Alterations in core histone composition can contribute to oncogenesis and chromatin-related diseases but are typically studied in the context of broad chromatin regulatory networks rather than individual canonical H2A members[2][4].

Other names
H2AC14H2A clustered histone 14H2A/EH2AFEHIST1H2AJHistone cluster 1 H2A family member jhistone cluster 1, H2ajdJ160A22.4
02

Mechanism of action

Not applicable (no specific drugs targeting H2A type 1-J; role in chromatin assembly and structure)

03

Biological functions

DNA packagingNucleosome assemblyRegulation of chromatin structureControl of gene expressionGenome stability
04

Disease associations

Cancer (altered chromatin structure and histone variants can be involved in cancer development)[2]Other (general role in genome stability and chromatin, but no highly specific disease singularly attributable to H2A type 1-J)
05

Safety considerations

None known (basic chromatin component; not a current direct therapeutic target)
06

Interacting drugs

None known (no direct pharmacological agents specifically target H2A type 1-J as of current knowledge)
07

Biomarkers

None known (no established use as a biomarker for patient selection or drug efficacy)

Beyond the preview

Go deeper on Histone H2A type 1-J (H2AC14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H2A type 1-J (H2AC14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call